iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Update

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large drop in short interest during the month of December. As of December 31st, there was short interest totaling 1,277 shares, a drop of 86.5% from the December 15th total of 9,491 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 17,516 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 17,516 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

Several institutional investors have recently added to or reduced their stakes in the business. Flow Traders U.S. LLC purchased a new position in shares of iShares Genomics Immunology and Healthcare ETF during the 2nd quarter worth $931,000. Portland Global Advisors LLC purchased a new position in shares of iShares Genomics Immunology and Healthcare ETF in the second quarter valued at about $2,099,000. Triumph Capital Management bought a new stake in iShares Genomics Immunology and Healthcare ETF in the 3rd quarter valued at $35,000. Finally, Ameriprise Financial Inc. boosted its stake in iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after buying an additional 5,540 shares during the last quarter.

iShares Genomics Immunology and Healthcare ETF Stock Down 0.6%

Shares of IDNA traded down $0.18 during mid-day trading on Monday, hitting $27.64. 32,626 shares of the company’s stock traded hands, compared to its average volume of 49,332. The business’s 50-day moving average price is $26.45 and its 200-day moving average price is $24.06. iShares Genomics Immunology and Healthcare ETF has a 1 year low of $17.26 and a 1 year high of $28.10. The firm has a market capitalization of $138.20 million, a P/E ratio of 14.76 and a beta of 1.07.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.